How much funding has Gisens Biotech raised?

Gisens Biotech has raised $420K in total funding, most recently a Seed round.

Who are Gisens Biotech's investors?

Gisens Biotech's investors include Techstars, Goff Capital, Alumni Ventures, Berkeley SkyDeck Fund.

When was Gisens Biotech founded?

Gisens Biotech was founded in 2024.

Where is Gisens Biotech headquartered?

Gisens Biotech is headquartered in Berkeley, California, United States.

What industry is Gisens Biotech in?

Gisens Biotech operates in Digital Health, Femtech, Healthcare, Nanotechnology.

How many employees does Gisens Biotech have?

Gisens Biotech has 1-10 employees.

Gisens Biotech

Revolutionizing diagnostics through nanotechnology

Berkeley, United States · Founded 2024 · $420K raised

Headquarters: Berkeley, California
Employees: 1–10
Founded: 2024
Business Model: B2B

Website: gisensbiotech.com
Total Funding: $420K
Last Round: $420K SeedSep 2024
Rounds: 1

About

Gisens Biotech develops graphene-based biosensor technology (G-LoC) that delivers real-time diagnostic results from patient samples in minutes with over 95.5% accuracy. Their flagship product KF4+ provides comprehensive kidney function testing for chronic kidney disease patients from home, integrating results directly into electronic health records. The company is backed by MassChallenge and the European Commission.

Summary

Gisens Biotech is a Digital Health company based in Berkeley, United States, founded in 2024. It has raised $420K in total across 1 round, most recently a $420K Seed round in Sep 2024. Investors include Techstars, Goff Capital and Alumni Ventures.